Evaluation of human fibroblast growth factor 23 (FGF-23) C-terminal and intact enzyme-linked immunosorbent-assays in end-stage renal disease patients.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Laboratory

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 19462937
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The phosphatonins and the regulation of phosphate transport and vitamin D metabolism.

  2007cited by this paper
• Fibroblast growth factor 23: the making of a hormone.

  2006cited by this paper
• FGF-23 and sFRP-4 in Chronic Kidney Disease and Post-Renal Transplantation

  2006cited by this paper
• Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.

  2006cited by this paper
• Fibroblast growth factor 23: roles in health and disease.

  2005cited by this paper
• Comparison of two assays for fibroblast growth factor (FGF)-23

  2005cited by this paper
• Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.

  2005cited by this paper
• Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.

  2005cited by this paper
• Sevelamer Hydrochloride and Calcium Bicarbonate Reduce Serum Fibroblast Growth Factor 23 Levels in Dialysis Patients

  2005cited by this paper
• The phosphatonin pathway: new insights in phosphate homeostasis.

  2004cited by this paper
• FGF-23 in patients with end-stage renal disease on hemodialysis.

  2004cited by this paper
• Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

  2003cited by this paper
• Molecular pathogenesis of hypophosphatemic rickets.

  2002cited by this paper
• Novel phosphate-regulating genes in the pathogenesis of renal phosphate wasting disorders

  2002cited by this paper
• Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

  2002cited by this paper
• Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin

  2002cited by this paper
• PHEX gene and hypophosphatemia.

  2000cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Determination of iFGF23 Upper Reference Limits (URL) in healthy pediatric population, for its better correct use

  2022cites this paper
• The Measurement and Interpretation of Fibroblast Growth Factor 23 (FGF23) Concentrations

  2022cites this paper
• Serum intact fibroblast growth factor 23 in healthy paediatric population

  2021cites this paper
• FGF23: A Review of Its Role in Mineral Metabolism and Renal and Cardiovascular Disease

  2021cites this paper
• Fibroblast growth factor 23: are we ready to use it in clinical practice?

  2020cites this paper
• Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis.

  2017cites this paper
• Stability of Fibroblast Growth Factor 23 in Human Plasma.

  2017influential citation
• C-Terminal to Intact Fibroblast Growth Factor 23 Ratio in Relation to Estimated Glomerular Filtration Rate in Elderly Population

  2016cites this paper
• Vitamin D Deficiency and Anemia in Heart Failure

  2015cites this paper
• Fibroblast Growth Factor 23, nicht jedoch lösliches Klotho, prädiziert akute kardiale Dekompensationen und Mortalität bei chronischer Nierenerkrankung

  2015cites this paper
• Fibroblast growth factor 23

  2014cites this paper
• Circulating α-klotho levels in CKD and relationship to progression.

  2013cites this paper
• Single FGF-23 measurement and time-averaged plasma phosphate levels in hemodialysis patients.

  2013cites this paper
• Circulating α-klotho levels in CKD and relationship to progression

  2013cites this paper
• FGF23: instability may affect accuracy and interpretation

  2013cites this paper
• FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages

  2012cites this paper
• FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.

  2010cites this paper
• Phosphate homeostasis and the renal-gastrointestinal axis.

  2010cites this paper
• Evaluation of a Method for Fibroblast Growth Factor-23: A Novel Biomarker of Adverse Outcomes in Patients with Renal Disease

  2010cites this paper